Instalab
logoInstalab

Pyridoxic Acid

Urine Test
An early read on your vitamin B6 turnover, a window into B6 status that standard panels rarely capture.
4.8 (3,547 reviews)
Physician-reviewed results
Results in under 1 week
How it works
Order from Instalab
No prescription or your own doctor's order needed
Collect your sample
At home
Get results
Explained with clear next steps, no medical jargon

Should you take a Pyridoxic Acid test?

This test is most useful if any of these apply to you.

Living With Diabetes or Kidney Issues
If you have type 2 diabetes or early kidney changes, this test can reveal B6 turnover patterns linked to long-term survival.
Taking B-Complex Supplements
This test shows whether your supplement is actually shifting your B6 status or just being excreted unused.
Worried About Inflammation
If you suspect chronic inflammation is driving your risk, B6 turnover offers a window into how fast your body is burning nutrients.
Healthy but Want to Stay Ahead
If your standard labs look fine but you want a sharper read on metabolic and nutrient status, this test adds a dimension routine panels miss.

About Pyridoxic Acid

Vitamin B6 quietly powers hundreds of reactions in your body, from making brain chemicals to processing protein. The catch: standard blood tests rarely look at it, and even when they do, a single snapshot can miss how fast your body is burning through it.

Urinary 4-PA (4-pyridoxic acid) is the main breakdown product your body excretes after using vitamin B6. Measuring it offers a window into recent B6 intake, how quickly your cells are turning over this vitamin, and how well your kidneys are clearing certain waste products.

What This Test Actually Captures

Vitamin B6 enters your body from food or supplements, gets converted in the liver into its active form, and then gets used up inside your cells. What's left over is 4-PA, which leaves the body through urine. Because urine is where this molecule exits, a urine measurement reflects how much B6 your body has recently processed.

In healthy adults, 4-PA is the dominant form of vitamin B6 found in urine, with other forms present in much smaller amounts. Research using a controlled feeding study in 19 adults (5 men and 14 women) showed a moderate positive correlation between the 4-PA-to-creatinine ratio from a random urine sample and a full 24-hour collection for tracking B6 status. That makes a single timed urine sample a reasonable, more practical alternative for many situations, though it captures less precision than a full 24-hour collection.

Why Tracking Turnover Matters More Than a Single Number

The most informative use of 4-PA isn't the absolute level but a ratio that compares 4-PA to the active form of vitamin B6 in blood. Researchers call this concept B6 turnover. Two related versions exist: the simpler 4-PA-to-PLP ratio (used in several U.S. national-survey studies) and the formal PAr index, which divides 4-PA by the sum of PL (pyridoxal) and PLP (pyridoxal 5'-phosphate). Both ratios capture similar biology and both tend to rise when there is ongoing inflammation in the body, but they are not identical.

Think of it this way: low B6 in your blood could mean you're not eating enough, or it could mean your body is burning through it faster than usual. The turnover ratio helps tell the difference, which has real consequences for what an intervention should look like.

All-Cause Mortality

Higher B6 turnover has been linked to a higher risk of dying from any cause. In a study of 15,304 adults from the general U.S. population, faster vitamin B6 breakdown was associated with greater all-cause mortality, with the association reaching statistical significance specifically among adults older than 65. A separate study of 4,881 older adults found that lower blood B6 levels combined with higher turnover rates were linked to greater cardiovascular and overall death risk.

Among 2,574 adults with type 2 diabetes, those with the lowest active B6 and the highest 4-PA had the worst survival. In a separate group of 2,074 people with type 2 diabetes, a higher 4-PA-to-PLP ratio was a strong predictor of long-term death, independent of standard inflammation and kidney markers. These findings are observational, so they show association, not proof of cause.

Cancer Risk

In the Hordaland Health Study of 6,539 community-dwelling adults, higher PAr (a B6 turnover ratio) predicted greater overall cancer incidence, especially lung cancer. The proposed mechanism is that increased B6 catabolism reflects systemic inflammation, a known driver of cancer risk. PAr added information beyond simple B6 intake.

Liver Fibrosis

An analysis of 8,063 adults from a U.S. national survey found that higher blood PLP was linked to lower odds of liver scarring, while a higher 4-PA-to-PLP ratio was linked to higher odds of scarring. The pattern held across age and health subgroups, suggesting B6 turnover tracks something real about underlying liver inflammation.

Kidney Function and Drug Clearance

More than 80% of 4-PA's removal by the kidneys flows through specific transporters in the OAT family, with OAT3 playing the dominant role and OAT1 also contributing. This makes urinary 4-PA an unusually clean readout of how well that transporter system is working. In a large kidney disease cohort, people whose kidneys cleared less 4-PA had a higher risk of disease progression, independent of standard markers like eGFR and urine protein.

What this means for you: if your urinary 4-PA looks off in the context of normal eGFR, it may reflect early changes in kidney tubular function that routine tests can miss. It also has implications for how your kidneys handle certain medications.

Type 2 Diabetes

In a study of 172 adults with type 2 diabetes compared to people without diabetes, those with diabetes had lower active B6 in blood but a higher proportion of 4-PA among total urinary B6 forms. The pattern is consistent with faster B6 breakdown in diabetes, particularly when early kidney involvement is present, though the cross-sectional design cannot prove that diabetes itself drives the shift. Sex differences also emerged, with women showing higher urinary 4-PA excretion than men.

Why One Reading Is Not Enough

Urinary 4-PA reflects recent vitamin B6 intake, typically over the past 1 to 2 weeks. That makes a single reading sensitive to what you ate this week, whether you took a multivitamin, and short-term hormonal shifts. In a small study of 34 healthy women, 4-PA showed menstrual-cycle rhythmicity, with lower values around ovulation tied to hormonal changes in B6 turnover. The evidence base for this cycle effect is thin and based on a single cohort.

Build a trend instead of trusting a single snapshot. Get a baseline reading. If you change something meaningful, such as starting a B-complex supplement, modifying your diet, or addressing a chronic inflammatory condition, retest in 3 to 6 months. Then check at least annually to confirm your levels and turnover ratio are stable. Pair urinary 4-PA with a blood PLP measurement so you can calculate the turnover ratio, which is more informative than either value alone.

When Results Can Be Misleading

Several factors can distort a single reading. Knowing them helps you avoid drawing the wrong conclusion:

  • Recent B6 intake: because 4-PA reflects the past 1 to 2 weeks of intake, a recent multivitamin, B-complex supplement, or B6-rich meal can elevate your reading without telling you anything about long-term status.
  • Kidney function: 4-PA excretion tracks closely with creatinine excretion. Impaired kidney function can lower urinary 4-PA even when blood levels rise, complicating interpretation.
  • Hormonal cycle: in menstruating women, limited data suggest 4-PA shifts across the cycle and is lower around ovulation. The phase of your cycle may matter when comparing readings.
  • Inflammation: active inflammation drives B6 turnover up, which can make your turnover ratio look unfavorable even if intake is adequate. This is information, not noise, but it means the ratio is reflecting your inflammatory state as much as your nutrition.

Decision Pathway When Results Look Off

If your urinary 4-PA is unexpectedly low, your first questions should be about intake. Are you eating B6-containing foods regularly? Are you on an oral contraceptive or other medication that influences B6 metabolism? Pair the result with a blood PLP test to determine whether active B6 in your bloodstream is also low, which would point toward true deficiency rather than just low recent intake.

If your turnover ratio (4-PA divided by PLP) is unexpectedly high, look for sources of inflammation. Order high-sensitivity CRP (hs-CRP, a blood marker of inflammation) and a comprehensive metabolic panel, and consider whether a chronic condition such as diabetes, autoimmune disease, or undiagnosed liver issues could be contributing. A nephrologist or metabolic specialist may be useful if kidney clearance appears compromised. If you have type 2 diabetes or kidney disease, the turnover ratio is worth tracking systematically as part of your long-term risk profile.

How to Collect a Useful Sample

Most labs accept either a 24-hour urine collection or a random spot urine sample with a creatinine measurement to normalize the result. The spot sample is far more practical and, based on controlled feeding research, gives results that correlate moderately well with a 24-hour collection, though with less precision. Collect when you're following your usual diet, not after an unusual meal or supplement binge, and note any recent B-vitamin supplementation so the lab interpretation is accurate.

What Moves This Biomarker

Evidence-backed interventions that affect your Pyridoxic Acid level

Increase
Take oral pyridoxine (vitamin B6) at typical supplemental doses
Direct vitamin B6 supplementation raises urinary 4-PA because more B6 enters the body and gets broken down for excretion. In a controlled human depletion-repletion study, B6 supplementation at 0.6 or 0.9 mg of pyridoxine significantly increased urinary 4-PA from baseline depleted levels. If your urinary 4-PA is low because of inadequate intake, this is the most direct way to raise it. Very high-dose pyridoxine supplementation (typically above 50 to 100 mg per day chronically) has been linked to peripheral nerve damage, so dosing should stay in normal supplemental ranges unless under medical supervision.
SupplementStrong Evidence
Increase
Take oral pyridoxamine, an alternative form of vitamin B6
Pyridoxamine supplementation raises both active blood B6 (PLP) and urinary B6 metabolites including 4-PA. In a small clinical study of 5 healthy adults, oral pyridoxamine was efficiently converted to PLP, and urinary B6 vitamer patterns shifted accordingly. This is relevant if you prefer pyridoxamine to standard pyridoxine for its proposed metabolic benefits.
SupplementStrong Evidence
Increase
Eat a diet adequate in B6-rich foods (poultry, fish, potatoes, bananas, fortified cereals)
Higher dietary B6 intake leads to higher urinary 4-PA excretion. In healthy adults, urinary 4-PA correlated with vitamin B6 intake, and the 4-PA-to-creatinine ratio from a random urine sample correlated moderately with 24-hour excretion. If your level is low, increasing dietary B6 is a low-risk first step before adding supplements.
DietModerate Evidence
Decrease
Take combined oral contraceptive pills
Oral contraceptive use has been linked to disturbances in vitamin B6 metabolism, including lower active B6 in blood. In a study cohort of 279 women, oral contraceptive users had altered vitamin B6 status with effects on related metabolic pathways, though these effects were not linked to inflammation markers. This is not a reason to stop contraception, but it is a reason to pay attention to your B6 status and consider modest supplementation if levels are low.
MedicationModerate Evidence

Frequently Asked Questions

Panels containing Pyridoxic Acid

Pyridoxic Acid is included in these pre-built panels.

References

17 studies
  1. Nix W, Zirwes R, Bangert V, Kaiser RP, Schilling M, Hostalek U, Obeid RDiabetes Research and Clinical Practice2014
  2. Van Den Eynde MD, Scheijen J, Stehouwer C, Miyata T, Schalkwijk CClinical Nutrition2021
  3. Thakur a, Mathialagan S, Kimoto E, Varma MCPT: Pharmacometrics & Systems Pharmacology2025
  4. Chen Y, Zelnick L, Wang K, Hoofnagle a, Becker JO, Hsu CY, Feldman H, Mehta RC, Lash J, Waikar S, Shafi T, Seliger S, Shlipak M, Rahman M, Kestenbaum BJournal of the American Society of Nephrology2020
  5. Ma L, Liu J, Deng M, Zhou L, Zhang Q, Xiao XDiabetology & Metabolic Syndrome2024